Joseph K Stanilla: Influence Statistics

Joseph K Stanilla

Joseph K Stanilla

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA (JKS) | Allegheny University of the Health Sciences, USA | Department of Psychiatry, ...

Joseph K Stanilla: Expert Impact

Concepts for which Joseph K Stanilla has direct influence: Clozapine treatment , Tardive dyskinesia , Water intoxication , Clozapine withdrawal , State hospital , Psychiatric patients , Psychiatric hospitals .

Joseph K Stanilla: KOL impact

Concepts related to the work of other authors for which for which Joseph K Stanilla has influence: Cigarette smoking , Patients schizophrenia , Nicotine dependence , Mental illness , Atypical antipsychotics , Tardive dyskinesia , Primary polydipsia .

KOL Resume for Joseph K Stanilla

Year
1999

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA (JKS)

1998

Allegheny University of the Health Sciences, USA

1997

Department of Psychiatry, Allegheny University, Norristown State Hospital, Pa. 19401, USA.

1996

Medical College of Pennsylvania, Eastern Pennsylvania Psychiatric Institute, Philadelphia, Pennsylvania, USA

1995

Medical College of Pennsylvania/Eastern Pennsylvania Psychiatric Institute, Department of Psychiatry, 3200 Henry Avenue, Philadelphia, US and Haverford State Hospital, Haverford, US

1994

From the Medical College of Pennsylvania at Eastern Pennsylvania Psychiatric Institute, Philadelphia, PA, USA

Prominent publications by Joseph K Stanilla

KOL-Index: 9048 . BACKGROUND: Akathisia has been reported to predict more severe symptoms and poorer treatment response to typical neuroleptics among patients with schizophrenia. Akathisia has also been associated with symptom exacerbation. This study addressed four questions: 1) Does akathisia predict greater severity in global psychopathology? 2) Is this effect global or specific? 3) Does clozapine ...
Known for Akathisia Psychopathology | Clozapine Treatment | 16 Weeks | Patients Schizophrenia
KOL-Index: 6897 . OBJECTIVE: This study explored the relative efficacy of three different doses of clozapine. METHOD: Fifty patients who met Kane et al.'s criteria for treatment-refractory schizophrenia or schizoaffective disorder were studied. All subjects were randomly assigned to 100, 300, or 600 mg/day of clozapine for 16 weeks of double-blind treatment. Forty-eight patients completed this first 16 ...
Known for Clozapine Dose | Chronic Schizophrenia | 600 Day | Response Treatment
KOL-Index: 5008 . This cross-sectional survey attempts to establish the prevalence of polydipsia and water intoxication at a state hospital (N = 360) using staff diagnosis, specific gravity of the urine (SPGU), weight changes, and chart review. There were 150 [42%, 95% confidence interval (CI) 37-47%] patients diagnosed as polydipsic by the staff or by SPGU. At least 93 (26%, CI 21-30%) had primary ...
Known for Water Intoxication | Primary Polydipsia | Psychiatric Hospital | Heavy Smoking
KOL-Index: 2542 . Neuroleptic-induced tardive dyskinesia (TD) negatively impacts the quality of life for persons with schizophrenia. While no satisfactory treatment is available for TD, a growing body of literature suggests the efficacy of clozapine in reducing TD. This paper describes the efficacy of clozapine in reducing TD in relation to the variables of treatment duration and dosage. Eighteen ...
Known for Tardive Dyskinesia | Quality Life | Effects Clozapine | Schizophrenic Patients
KOL-Index: 2394 . Misidentification syndromes represent false, delusionally-based identification of self and/or others. These are variants of the Capgras Syndrome. Although the frequency of misidentification syndromes in schizophrenic populations has not yet been established, the authors believe this syndrome is more prevalent than previously described. Seven of twenty-five (28%) consecutive patients ...
Known for Misidentification Syndrome | Schizophrenia Schizophrenic | Psychotic Disorders | Adult Capgras
KOL-Index: 1852 . The diurnal and weekly variability of tardive dyskinesia (TD) was assessed instrumentally by digital image processing. Weekly assessments were obtained in ten patients over a 6-week period. In six of the ten patients, assessments were obtained four times over a single 12-h period. Results indicate that TD movements measured by instrumental assessment vary from week to week and throughout ...
Known for Tardive Dyskinesia | Digital Image | Induced Female | 6 Week
KOL-Index: 1239
Known for Clozapine Levels | Antipsychotic Agents | Substance Withdrawal | Syndrome Adult
KOL-Index: 834
Known for Clozapine Therapy | Epilepsies Myoclonic

Key People For Clozapine Treatment

Top KOLs in the world
#1
Herbert Yale Meltzer
major depression antipsychotic drugs weight gain
#2
John Michael Kane
tardive dyskinesia patients schizophrenia bipolar disorder
#3
Jeffrey A MD Lieberman
tardive dyskinesia weight gain episode schizophrenia
#4
Gilbert Honigfeld
clozapine therapy psychiatric patients multicenter trial
#5
Jack Singer
neuroleptic nonresponders multicenter trial chlorpromazine treatment
#6
David Michael Taylor
atypical antipsychotics clozapine treatment serotonin syndrome

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA (JKS) | Allegheny University of the Health Sciences, USA | Department of Psychiatry, Allegheny University, Norristown State Hospital, Pa. 19401, USA. | Medical Coll